Author:
Glehen O.,Kepenekian V.,Bouché O.,Gladieff L.,Honore C.,Abba J.,Abboud K.,Arvieux C.,Bakrin N.,Delhorme J.-B.,Dartigues P.,Durand-Fontanier S.,Eveno C.,Fontaine J.,Gelli M.,Goere D.,Guyon F.,Lefevre J.,Lo Dico R.,Marchal F.,Nadeau C.,Paquette B.,Pezet D.,Pocard M.,Rousset P.,Sgarbura O.,Taibi A.,Tuech J.-J.,You B.,Villeneuve L.
Reference33 articles.
1. A perioperative clinical pathway can dramatically reduce failure-to-rescue rates after cytoreductive surgery for peritoneal carcinomatosis: a retrospective study of 666 consecutive cytoreductions;Passot;Ann Surg,2017
2. Prehabilitation of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancy;Cortes-Guiral;Eur J Surg Oncol,2020
3. COVID-19 epidemic: proposed alternatives in the management of digestive cancers: a French Intergroup clinical point of view (TNCD);Di Fiore;Dig Liver Dis,2020
4. Evaluation of the peritoneal carcinomatosis index with CT and MRI;Dohan;Br J Surg,2017
5. Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: history, clinical applications, and implementation;Low;Eur J Surg Oncol,2019